These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. Weinbrenner C; Liu GS; Cohen MV; Downey JM J Mol Cell Cardiol; 1997 Sep; 29(9):2383-91. PubMed ID: 9299362 [TBL] [Abstract][Full Text] [Related]
9. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart. Sanada S; Kitakaze M; Papst PJ; Hatanaka K; Asanuma H; Aki T; Shinozaki Y; Ogita H; Node K; Takashima S; Asakura M; Yamada J; Fukushima T; Ogai A; Kuzuya T; Mori H; Terada N; Yoshida K; Hori M Circ Res; 2001 Feb; 88(2):175-80. PubMed ID: 11157669 [TBL] [Abstract][Full Text] [Related]
11. Comparison between ischaemic and anisomycin-induced preconditioning: role of p38 MAPK. Lochner A; Genade S; Hattingh S; Marais E; Huisamen B; Moolman JA Cardiovasc Drugs Ther; 2003 May; 17(3):217-30. PubMed ID: 14574080 [TBL] [Abstract][Full Text] [Related]
12. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK. Weber NC; Toma O; Wolter JI; Obal D; Müllenheim J; Preckel B; Schlack W Br J Pharmacol; 2005 Jan; 144(1):123-32. PubMed ID: 15644876 [TBL] [Abstract][Full Text] [Related]
13. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Tanno M; Bassi R; Gorog DA; Saurin AT; Jiang J; Heads RJ; Martin JL; Davis RJ; Flavell RA; Marber MS Circ Res; 2003 Aug; 93(3):254-61. PubMed ID: 12829618 [TBL] [Abstract][Full Text] [Related]
14. Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes. Miura T; Miura T; Kawamura S; Goto M; Sakamoto J; Tsuchida A; Matsuzaki M; Shimamoto K Cardiovasc Res; 1998 Mar; 37(3):700-9. PubMed ID: 9659454 [TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation. Tanno M; Gorog DA; Bellahcene M; Cao X; Quinlan RA; Marber MS J Mol Cell Cardiol; 2003 Dec; 35(12):1523-7. PubMed ID: 14654378 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling. Das S; Tosaki A; Bagchi D; Maulik N; Das DK J Pharmacol Exp Ther; 2006 Jun; 317(3):980-8. PubMed ID: 16525036 [TBL] [Abstract][Full Text] [Related]
17. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways. Heidbreder M; Naumann A; Tempel K; Dominiak P; Dendorfer A Cardiovasc Res; 2008 Apr; 78(1):108-15. PubMed ID: 18096574 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Ma XL; Kumar S; Gao F; Louden CS; Lopez BL; Christopher TA; Wang C; Lee JC; Feuerstein GZ; Yue TL Circulation; 1999 Apr; 99(13):1685-91. PubMed ID: 10190877 [TBL] [Abstract][Full Text] [Related]
19. Role of p38 mitogen-activated protein kinases in cardioprotection of morphine preconditioning. Zhang Y; Gu EW; Zhang J; Chen ZW Chin Med J (Engl); 2007 May; 120(9):777-81. PubMed ID: 17531118 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death. Barancik M; Htun P; Strohm C; Kilian S; Schaper W J Cardiovasc Pharmacol; 2000 Mar; 35(3):474-83. PubMed ID: 10710135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]